Corporate News Report
Intensity Therapeutics Inc. (NASDAQ: INTS)
- Trading session ending: 08:38 PM Central Europe, Thursday 22 Oct 2026
- Price change: –4.18 % in the last 24 hours
- Current share price: USD 3.19
- Shares outstanding: 3.3 million
- Market capitalization: USD 10.7 million
- 24‑hour trading volume: USD 30.8 thousand
- Price trend since previous month‑end: –21.62 %
- 200‑day simple moving average: USD 5.47
- 52‑week high: USD 43.5 (30 Oct 2025)
- 52‑week low: USD 3.10 (13 Oct 2026)
Related Stock Performance (Last 24 hours)
| Symbol | Company | % Move | Current Price | Market Cap |
|---|---|---|---|---|
| PASG | Passage Bio | –0.28 % | USD 3.79 | USD 11.6 M |
| AIRI | Air Industries | +1.21 % | USD 2.51 | USD 12.0 M |
| BFRI | Biofrontera | –0.50 % | USD 0.81 | USD 11.9 M |
| CETY | Clean Energy | +3.21 % | USD 0.96 | USD 11.7 M |
| NBVAF | Nubeva | 0.00 % | USD 0.16 | USD 11.9 M |
Highlights
Air Industries (AIRI): Third‑quarter operating results remained broadly flat compared with the prior year. Revenue was essentially unchanged; modest decline in telecom service income was offset by an increase in international software services. Comparable EBITDA and EBIT slipped slightly, reflecting ongoing cost‑saving initiatives and the impact of a discontinued public‑switched‑telephone network. Cash flow from operations contracted mildly, while the debt profile remained stable. The company highlighted a significant new contract with a major cloud provider for data‑center connectivity and progress in artificial‑intelligence‑driven network solutions. Management expressed confidence that strategic transformations will deliver targeted savings and improve efficiency over the year.
Clean Energy Technologies (CETY): Announced deployment of its heat‑pump system in Washington, D.C. The unit will operate alongside a conventional HVAC system in a large apartment building. The project is part of a trial to demonstrate performance and energy‑saving potential of the technology, which uses metal‑organic frameworks to remove moisture before cooling. Data from the test will be released to inform building owners about the feasibility of all‑electric heating and cooling solutions. The project received a grant from the Clean Fight’s National Deployment Grant Fund. The company has already deployed its system at Amazon logistics sites under a multi‑year agreement and is scaling production through a partnership with KCC Companies in the United States.
About Intensity Therapeutics
Intensity Therapeutics Inc. is a biomedical service provider that specializes in human clinical testing for refractory solid‑tumor cancers. The company is headquartered in Westport, United States, serves a global customer base, and is listed on the Nasdaq stock exchange. Its initial public offering was on 2 December 2021.